|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K2039/505 | (2013.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/26 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/14 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 9/08 | (2018.01) | ||
| A61P 13/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 15/04 | (2018.01) | ||
| A61P 15/12 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| C07K 16/18 | (2013.01) | ||
| C07K 16/26 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/56 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) |
| (11) | Number of the document | 3165236 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16202020.0 |
| Date of filing the European patent application | 2010-08-23 | |
| (97) | Date of publication of the European application | 2017-05-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 237901 | 2009-08-28 | US |
| (72) |
Pios, Ariel, Ates , US
Poulsen, Kristian, Todd , US
Shelton, David Louis , US
Zeller, Joerg , US
|
| (73) |
Teva Pharmaceuticals International GmbH ,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE |
| METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE |